MAPK3 and Miyoshi myopathy: By densitometric analysis, macitentan significantly reduced p-erk1/2 levels both in resting and ET-1-stimulated cell lines (Figure 1A), thus showing its capacity to antagonize either the autocrine (8) and paracrine activation of ET-1 axis in MM cells.